Nykode Therapeutics ASA financial statements
Nykode Therapeutics ASA's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 12.24M | EODHD |
| Cash and equivalents | USD 60.29M | EODHD |
Nykode Therapeutics ASA financials on 6ix · Nykode Therapeutics ASA on 6ix